Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

Clinical trial NCT00369564 · COMPLETED

Trial details

NCT number: NCT00369564
Sponsor: University of South Florida
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Cancer Leukemia Lymphoma Neurotoxicity Peripheral Neuropathy Sarcoma

Start date: 2007-05-01
Primary completion: 2012-11-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.